Sector
Technology
Industry
Hardware, Equipment & Parts
Employees
1027
First IPO Date
October 21, 2016
| Name | Title | Pay | Year Born |
| Jean-Marc Gendre | Deputy General Director & Chief Executive Officer of Lumibird Medical | 246,992 | N/A |
| Marc Le Flohic | Chief Executive Officer & Chairman | 503,651 | 1963 |
| Andrew Moysey | Group Chief Financial Officer | 0 | N/A |
| Frederic Chiquet | Chief Corporate Social Responsibility Officer | 0 | N/A |
| Nicolas Ballif | Director of Human Resources | 0 | N/A |
| Nigel Holehouse | Program Director | 0 | N/A |
| Philippe Metivier | Director of Research & Development | 0 | 1961 |
| Pierre-Franasois Chenevier | Deputy General Director & General Director of Photonics Division | 0 | N/A |
| Alexandre Billard | Director of the Photonics Division & Purchasing Director | 0 | N/A |
| Aude Nomblot-Gourhand | Financial Director | 0 | N/A |
| Sonia Rutnam | Chief Transformation Officer | 0 | N/A |
Lumibird SA specializes in the development, manufacturing, and commercialization of laser devices. Headquartered in Lannion, Bretagne, the company employs 541 dedicated full-time staff. Its extensive product offering includes various laser types such as compact pulsed and double-pulse Nd lasers, customizable laser systems, flash-lamp pumped lasers, diode-pumped solid-state lasers, semiconductor laser modules, and powerful intense pulsed light instruments. Lumibird provides its advanced laser solutions to a broad spectrum of clients, spanning industrial, scientific, and medical sectors. The firm operates globally through key subsidiaries, including Quantel Medical, which focuses on diagnostic ocular ultrasound systems and surgical lasers; Quantel USA, renowned for designing and producing fiber, glass, and tunable laser systems; and Quantel Derma AT, which concentrates on laser technology for dermatological and aesthetic applications.